logo
← ETF screener

Direxion Nanotechnology ETF

TYNE

Direxion

Direxion Nanotechnology ETF (TYNE) on the Akinda fund screen (AAOIFI-derived): Not halal. Coverage 96.23%. Below: the fund under all five rulebooks, its facts and every holding with its own verdict.

Akinda fund screen

Akinda fund screen (AAOIFI-derived)Not halalCoverage: 96.23%
  • Halal 46.48%
  • Doubtful 2.74%
  • Not halal 47.01%
  • Not rated 3.77%

The bar is scaled to fit; the figures are as reported, and the buckets do not always total 100%.

Coverage is the share of the fund's weight we hold a usable verdict for. Below 95%, a fund is rated only when the weight we can see already breaches the 5% limit; otherwise it is not rated by this method.

Fund facts

Issuer
Direxion
Venue (where it trades)
United States
Domicile (where it is registered)
United States
Reporting currency
USD
Expense ratio
0.65%
AUM
1.32M USD
Holdings
30 (26 screened)
Basket as of (provider)
30 Aug 2026
Basket fetched by Akinda
23 Oct 2026
Verdict updated
3 Nov 2026

Venue is where a fund trades; domicile is where it is registered. London-listed funds are domiciled in Ireland or Luxembourg, so use Venue for UK ETFs.

Five rulebooks

RulebookVerdictHalalNot halalSplit (0–100%)
Akinda fund screen (AAOIFI)Not halal46.48%47.01%
DJIMNot halal46.48%44.55%
FTSENot halal30.58%59.81%
MSCINot halal30.58%59.81%
S&PNot halal51.85%36.80%

Every bar uses the same 0–100% scale. Index rulebooks report only halal and not-halal weight; uncoloured weight is weight that rulebook does not classify. Coverage is published for the Akinda fund screen only.

The fund screen and the four index rulebooks answer different questions, so they are expected to disagree. A fund can be doubtful on our fund screen and halal under S&P; both are correct.

Holdings

1–30 of 30 holdings, largest first · basket as of 30 Aug 2026
No.HoldingWeightAkinda (AAOIFI)DJIMFTSEMSCIS&P
1
LQDALiquidia Technologies Inc
6.10%HalalHalalNot halalNot halalHalal
2
BNGOBioNano Genomics Inc
5.37%Not halalNot halalHalalHalalHalal
3
ARCTArcturus Therapeutics Holdings Inc
5.24%Not halalNot halalNot halalNot halalNot halal
4
ROIVROIVANT SCIENCES LTD
4.65%Not halalNot halalNot halalNot halalNot halal
5
NNDMNANO DIMENSION LTD USD 1.0 ADR
4.65%Not halalNot halalNot halalNot halalNot halal
6
ALKSALKERMES PLC
3.37%HalalHalalNot halalNot halalHalal
7
CBTCabot Corp.
3.09%HalalHalalNot ratedNot ratedHalal
8
LRCXLAM RESEARCH
3.06%HalalHalalHalalHalalHalal
9
KLACKLA-Tencor Corp.
2.96%HalalHalalHalalHalalHalal
10
TMOThermo Fisher Scientific Inc
2.94%HalalHalalNot halalNot halalHalal
11
LITELUMENTUM HLDGS INC USD 0.001
2.92%HalalHalalNot halalNot halalHalal
12
ALNYAlnylam Pharmaceuticals Inc
2.84%HalalHalalNot halalNot halalHalal
13
JAZZJAZZ PHARMACEUTICALS PLC USD 0.0001
2.79%Not halalNot halalNot halalNot halalNot halal
14
DHRDanaher Corp.
2.76%HalalHalalHalalHalalHalal
15
IEXIDEX Corp.
2.72%DoubtfulNot ratedNot ratedNot ratedNot rated
16
MRNAModerna Inc
2.66%Not halalNot halalNot halalNot halalNot halal
17
ANGOAngiodynamics Inc
2.60%HalalHalalHalalHalalHalal
18
VUZIVuzix Corp
2.46%Not halalNot ratedNot halalNot halalNot rated
19
BNTXBIONTECH SE
2.39%Not halalNot halalNot halalNot halalNot rated
20
NTLAIntellia Therapeutics Inc
2.29%Not halalNot halalNot halalNot halalNot halal
21
MMATMETA MATERIALS INC
2.02%Not ratedNot ratedNot ratedNot ratedNot rated
22
PDSBPDS BIOTECHNOLOGY CORP
1.99%Not halalNot halalNot halalNot halalNot halal
23
BRKRBruker Biosciences Corp
13.83%HalalHalalHalalHalalHalal
24
BEAMBeam Therapeutics Inc
11.13%Not halalNot halalNot halalNot halalNot halal
25
SEERSEER INC
0.82%Not halalNot halalNot halalNot halalNot halal
26
AADIAADI BIOSCIENCE INC
0.70%Not ratedNot ratedNot ratedNot ratedNot rated
27
NVECNve Corp Com New
0.59%Not halalNot halalNot halalNot halalNot halal
28
GBIOGENERATION BIO CO
0.55%Not ratedNot ratedNot ratedNot ratedNot rated
29
VIEWVIEW INC
0.51%Not ratedNot ratedNot ratedNot ratedNot rated
30
AMEAmetek
0.02%DoubtfulNot ratedNot ratedNot ratedNot rated

Not rated means we hold no usable verdict for that company; it is never treated as compliant.

How Akinda screens funds and stocks